• Investors
  • News
  • Subscribe
Cardax, Inc. | CDXI Cardax, Inc. | CDXI
  • About Us
    • Corporate Overview
    • Corporate Presentation
    • Management Team
    • Board of Directors
    • Lead Scientific Team
    • Company History
    • Intellectual Property
  • Astaxanthin
    • Overview
    • History and Background
    • Benefits of Use
    • Manufacturing
    • Scientific Literature
  • Commercialization
    • Strategy
    • Addressable Markets
    • Other Programs
  • Newsroom
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Investor Relations

Press Releases
Investors
  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors

Jun 1, 2018

Cardax Reports Q1 2018 Results

May 9, 2018

Cardax Announces Warrant Exchange Offer

May 2, 2018

Cardax Reports 2017 Results

Mar 27, 2018

Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores

Feb 17, 2018

Cardax Inks Deal to Distribute ZanthoSyn® in China

Feb 17, 2018

ZanthoSyn® from Cardax Now Available at 3,000+ GNC Corporate Stores in the U.S.

Dec 7, 2017

Cardax Hires Gilbert Shin as VP, Retail Sales and Marketing

Dec 7, 2017

Cardax Refutes Allegations by Competitive Trade Group, NAXA

Dec 5, 2017

Cardax Reports Q3 2017 Results

Nov 14, 2017
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7

    News / Events

    • Press Releases
    • Media Coverage
    • IR Calendar
    • Presentations
    • Email Alerts
    Subscribe to Receive Updates by E-Mail Cardax News Alerts

    About Cardax

    Cardax is developing safe anti-inflammatory dietary supplements and drugs utilizing astaxanthin.

    Recent News

    • Cardax to Present at NobleCon XVJanuary 25, 2019
    • Cardax and GNC Announce Expanded ZanthoSyn® Sales and Marketing ProgramDecember 3, 2018

    Quick Links

    • Company Overview
    • About Astaxanthin
    • Newsroom
    • Investors
    • Contact Us
    • ZanthoSyn™

    Contact Us

    Cardax, Inc.
    2800 Woodlawn Drive, #129
    Honolulu, Hawaii 96822
    Phone: (808) 457-1400

    info@cardaxpharma.com
    investors@cardaxpharma.com
    press@cardaxpharma.com

    © 2019 Cardax, Inc. | Disclaimer and Terms of Use

    • About Us
      • Corporate Overview
      • Corporate Presentation
      • Management Team
      • Board of Directors
      • Lead Scientific Team
      • Company History
      • Intellectual Property
    • Astaxanthin
      • Overview
      • History and Background
      • Benefits of Use
      • Manufacturing
      • Scientific Literature
    • Commercialization
      • Strategy
      • Addressable Markets
      • Other Programs
    • Newsroom
    • Investors
      • Overview
      • News / Events
      • Company Information
      • Financial Information
      • Stock Data
      • SEC Filings
      • Corporate Governance
    • Contact Us